Special Situations
We focus on idiosyncratic real estate opportunities across the UK and Europe
Funding Solutions
Zenzic invests in all major real estate sectors, across the capital structure and on a short and longer term basis (12 months to 5 years +). This investment flexibility allows us to tailor our funding to transaction requirements and to capture alpha wherever it arises.
Our team is drawn from leading real estate credit institutions with operational responsibility for over $2bn AUM. We pride ourselves on the quality of our research, the thoroughness of our diligence and the precision and ingenuity of our deal execution.
Growth
Zenzic takes a strategic equity stake alongside exceptional management teams in differentiated real estate platforms.
- Zenzic provides capital - typically on a preferred equity basis - and gives management support to assist the business to scale and exploit the market opportunity to its full potential.
- Sectors: Selected, based on Zenzic view of relative sector strength and outlook
- Investment structure: JV / Preferred Equity
Loan Term
Ticket Size
Liquidity
Providing solution-based capital for liquidity requirements caused by factors unrelated to risk including:
- Transaction complexity, inc. accelerated transaction timetable, non-vanilla collateral package
- Retrenchment of traditional capital providers
- Strong balance sheet / weaker cash flow scenarios
- Relative nascence of sector; sector agnostic
- Investment Structure: Senior and Junior Secured facilities
Loan Terms
Ticket Size
Di(Stressed)
Opportunistic led transactions in stressed or distressed scenarios including:
- Rescue financing and/or restructuring intensive transactions
- Acquiring assets in distressed or urgent sales context
- Purchase of NPLs on single or portfolio basis
Loan Term
Ticket Size
News and Insights
UBS and Reed confirm £900m life sciences deal with GSK
Post the COVID-19 pandemic, the importance of a high-class life science industry is self-evident. Yet the scale of the industry,
Why this is the ‘Golden Era of Credit’?
Interesting to hear Bruce Richards discussing with Institutional Investor why he believes for the first time in 20 years, credit
Weakening credit and tightening lending conditions drive compelling value
Came across an interesting report by PIMCO who, like us, believe higher interest rates and tighter lending conditions are creating
Senior homes on the up – but UK still faces huge shortfall
Zenzic has long viewed senior living housing as a growth sector and it’s good to see React News reporting that
Funds Europe ‘Women in Alternatives’ webinar with Nadine Buckland
Nadine Buckland joined Funds Europe’s live-streamed webinar, with a panel of industry experts who shared insights relating to their careers
Dr. Dorothy Kelso Interview with Zenzic Capital Nadine Buckland
Our co-founder, Nadine Buckland was recently interviewed by the amazing Dr. Dorothy Kelso about Zenzic’s journey over the last ten
UBS and Reed confirm £900m life sciences deal with GSK
Post the COVID-19 pandemic, the importance of a high-class life science industry is self-evident. Yet the scale of the industry,
Why this is the ‘Golden Era of Credit’?
Interesting to hear Bruce Richards discussing with Institutional Investor why he believes for the first time in 20 years, credit
Weakening credit and tightening lending conditions drive compelling value
Came across an interesting report by PIMCO who, like us, believe higher interest rates and tighter lending conditions are creating
Senior homes on the up – but UK still faces huge shortfall
Zenzic has long viewed senior living housing as a growth sector and it’s good to see React News reporting that
Funds Europe ‘Women in Alternatives’ webinar with Nadine Buckland
Nadine Buckland joined Funds Europe’s live-streamed webinar, with a panel of industry experts who shared insights relating to their careers
Dr. Dorothy Kelso Interview with Zenzic Capital Nadine Buckland
Our co-founder, Nadine Buckland was recently interviewed by the amazing Dr. Dorothy Kelso about Zenzic’s journey over the last ten
Get in Touch to discuss your funding requirements
"*" indicates required fields